Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 165

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 165
---
 largely technology driven. Intellectual property rights, particularly patents and trade secrets,
can play a significant role in protecting products. Patents enable us to stop unauthorized third parties from making, using, selling,
offering for sale or importing products that are covered under valid and enforceable patents. Trade secrets enable us to protect information
that we do not wish to divulge to the public. Trademarks also play a role in product differentiation and branding. If we are unable to
adequately protect our intellectual property and proprietary technology, competitors may be able to use our technologies or the goodwill
we have acquired in the marketplace, and erode or negate any competitive advantage we may have, which could ultimately harm our business
and ability to achieve profitability. In order to protect our intellectual property, we may be involved in intellectual property litigation,
which is inherently complex, expensive and unpredictable.

We have in-licensed
patents and pending patent applications, and we hold patents and pending patent applications. However, our competitors may seek to produce
products that include aspects of our technologies that are not subject to patent protection, which may negatively affect our business.
Further, the patent applications we in-license and own may not result in issued patents.

The patents we
rely on may not be sufficiently broad to protect our technology or to give us any competitive advantage. We are unable to provide any
assurances that any of our patents, or patents to which we have rights through licensing agreements, have, or that any of the pending
patent applications that mature into issued patents that we own or in-license will include, claims with a scope sufficient to protect
our technology or products, any additional features we develop with respect to our technology or products, or any new technology or products
that we seek to develop in the future. These patents could be challenged as invalid or unenforceable, or circumvented by competitors.
Medical device and biological and pharmaceutical product patents involve complex legal, scientific and factual questions, and therefore,
the issuance, scope, validity and enforceability of any patent claims that we or our licensors may obtain cannot be predicted with certainty.
Any patents for which we or our licensors have applied may not be granted. Third parties own numerous U.S. and foreign issued patents
and pending patent applications in the fields in which we have developed our technology or in which we plan to manufacture and sell our
products. Such third party- owned patents can be an obstacle to the ability for us or our licensors to obtain patent protection that covers
our technology.

|